Drug package

- Amicus Therapeutics, Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front top right perspective view of a drug package showing our new design;

FIG. 2 is a back top left perspective view thereof;

FIG. 3 is a top view thereof;

FIG. 4 is a bottom view thereof;

FIG. 5 is a front view thereof;

FIG. 6 is a back view thereof;

FIG. 7 is a right view thereof; and,

FIG. 8 is a left view thereof.

The broken lines depict environmental subject matter only and form no part of the claimed design.

Claims

The ornamental design for a drug package, substantially as shown and described.

Referenced Cited
U.S. Patent Documents
D263559 March 30, 1982 Poore
D320930 October 22, 1991 Richards
D339742 September 28, 1993 Walchek, Jr.
D441192 May 1, 2001 Park
D455958 April 23, 2002 Burrus
D478810 August 26, 2003 Wilson
D505320 May 24, 2005 Gattefosse
D511465 November 15, 2005 Smith
D513981 January 31, 2006 Gibbs
D521862 May 30, 2006 Siethoff
D528013 September 12, 2006 Hines
D539166 March 27, 2007 Spencer
D540665 April 17, 2007 Gupta
D546198 July 10, 2007 Currie
D553494 October 23, 2007 Dehlin
D562153 February 19, 2008 Ruble
D592047 May 12, 2009 Glass
D599654 September 8, 2009 Kosaka
D622158 August 24, 2010 Proulx
D658069 April 24, 2012 Boyer
D702116 April 8, 2014 Buchanan
D715634 October 21, 2014 Stevens
D723390 March 3, 2015 Eriksson
D748978 February 9, 2016 Glass
D770303 November 1, 2016 Gelbaum
D789196 June 13, 2017 Waters
D795083 August 22, 2017 Safiullin
D806570 January 2, 2018 Gelbaum
D828767 September 18, 2018 von Badinski
Foreign Patent Documents
2015/164210 October 2015 WO
Other references
  • MWV introduces Shellpak Renew with Optilock. [online] Published on Dec. 23, 2014. Retrieved Mar. 8, 2018 from URL: https://www.businesswire.eom/news/home/20130808005877/en/MWV-introduces-Shellpak%C2%AE-Renew-Optilock%E2%84%A2-technology-smallest.
  • “Amicus Therapeutics Announces European Commission Approval for Galafold™ (Migalastat) in Patients with Fabry Disease in European Union”, Amicus Therapeutics Press Release, May 31, 2016, 3 pages.
  • File History for U.S. Appl. No. 29/585,388, 108 pages.
  • Galafold 123 mg Packaging in German, May 30, 2016, 2 pages.
  • Galafold Product Information, May 30, 2016, 45 pages.
  • NDA 208623 Accelerated Approval Letter and Labeling, Aug. 10, 2018, 40 pages.
Patent History
Patent number: D877625
Type: Grant
Filed: May 30, 2017
Date of Patent: Mar 10, 2020
Assignee: Amicus Therapeutics, Inc. (Cranbury, NJ)
Inventors: Jeffrey LoPrete (Cranbury, NJ), Muzammil Mustufa (Cranbury, NJ), Jayne Gershkowitz (Cranbury, NJ)
Primary Examiner: Vy N Koenig
Application Number: 29/605,763
Classifications
Current U.S. Class: D9/732